BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Alzheimer's disease
Artificial intelligence
Biosimilars
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Friday, April 19, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
June 1, 2004
View Archived Issues
Medivir continued to make progress during interim period
Read More
Update on natalizumab in Crohn's disease
Read More
Therapeutic benefits of cilansetron in IBS
Read More
Semapimod suggested to be effective in Crohn's disease
Read More
Pharmacokinetics and safety of fontolizumab in Crohn's disease
Read More
MorphoSys highlights Q1 developments
Read More
Telik highlights Q1 developments
Read More
Extracts from Korean red ginseng roots reduce blood pressure in hypertensive patients
Read More
TLR2 antibody may prevent septic shock
Read More
Oncolytic adenovirus targets colon cancer cells with deregulated wnt pathway in vivo
Read More
Novel anti-HIV agent targets RNase H activity
Read More
Novel small molecule inhibitor of human rotavirus
Read More
SciClone and Nektar Therapeutics collaborate on pegylated Zadaxin
Read More
European approval for new Enbrel indication
Read More
LC16m8 smallpox vaccine demonstrates effectiveness in animal studies
Read More
Approval for Gonal-f Pen for infertility
Read More
Pharmaceutical Resources changes name to Par Pharmaceutical Companies
Read More
FDA sets date to discuss Macugen NDA
Read More
Dosing commences in phase II trial of Albuferon for chronic HCV
Read More
Enrollment under way in confirmatory phase III trial of Sebazole
Read More
Orphan drug status for PD-6735
Read More
Anadys selects ANA-975 as development candidate for HCV
Read More
AEterna Zentaris unveils new name, progress and plans
Read More
Atiprimod enters new phase I/II trial in relapsed multiple myeloma
Read More
Zemplar approved for pediatric use
Read More
UCB to acquire Celltech
Read More
Encore claims esters of R-NSAIDs and their therapeutic use
Read More
Two series of MMP, TACE and/or aggrecanase inhibitors presented by BMS
Read More
Dual PDE3/L-type Ca2+ channel inhibitors covered by Artesian patent
Read More
Novel beta2-adrenoceptor agonists discovered at Boehringer Ingelheim
Read More
New aminopeptidase N inhibitors and their use in atherosclerosis and other disorders
Read More
Roche researchers describe 5-HT receptor ligands for psychoses, dementia, etc.
Read More
Pfizer claims novel p38 MAP kinase inhibitors in a recent patent
Read More
Cizolirtine completes phase II trials in urinary incontinence
Read More